Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics Announces Participation in Upcoming Conferences

PHILADELPHIA, May 7, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides in...
April 17, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Reports First Quarter 2015 Financial Results

Commenced enrollment in mid-dose arm of MDGN-201 study Initiated peritoneal dialysis study in Israel Filed U.S. IND for TARGTEPO renal anemia programs Advanced collaboration...
April 02, 2015 16:01 ET | Source: Medgenics, Inc.

Medgenics to Host Conference Call to Announce First Quarter 2015 Results on April 17, 2015

PHILADELPHIA, April 2, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Friday, April 17, 2015 at 8:30 a.m. ET to discuss first quarter 2015...
March 02, 2015 16:01 ET | Source: Medgenics, Inc.

Medgenics to Present at Upcoming Investor Conferences

PHILADELPHIA, March 2, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
February 13, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Reports Fourth Quarter and Full Year 2014 Financial Results

Proof of concept established for TARGTTM platform Enrollment initiated in mid-dose arm of MDGN-201 study; low-dose arm fully enrolled Preclinical peptide programs...
January 30, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics to Host Conference Call to Announce Fourth Quarter and Full Year 2014 Results on February 13, 2015

PHILADELPHIA, Jan. 30, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Friday, February 13, 2015 at 8:30 a.m. ET to discuss fourth quarter...
January 08, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics to Present at Biotech Showcase 2015 Conference

PHILADELPHIA, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
December 01, 2014 16:01 ET | Source: Medgenics, Inc.

Medgenics Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock

PHILADELPHIA, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
November 25, 2014 16:01 ET | Source: Medgenics, Inc.

Medgenics to Present at 26th Annual Piper Jaffray Healthcare Conference

PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
November 25, 2014 09:00 ET | Source: Medgenics, Inc.

Medgenics Prices Public Offering of Common Stock

PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced the pricing of 5,125,000 shares of its common stock in a previously announced underwritten public...